Skip to content
AwardedSpainGoods

2ª PRORROGA ACUERDO MARCO PROCEDIMIENTO ABIERTO SUMINISTRO DE EVEROLIMUS 5 Y 10 MG ORAL (ANTINEOPLÁSICO) CON DESTINO AL SERVICIO DE FARMACIA DEL HCSC

Published
Published 29 August 2025

Overview

2ª PRORROGA ACUERDO MARCO PROCEDIMIENTO ABIERTO SUMINISTRO DE EVEROLIMUS 5 Y 10 MG ORAL (ANTINEOPLÁSICO) CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS DE MADRID

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Open
Published
29 August 2025
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€63,268
Award date
1 August 2025
Winners
  • ACCORD HEALTHCARE,S.L
  • BIOPHARMED IBERICA SL,
  • LABORATORIO STADA, S.L
  • REDDY PHARMA IBERIA SA
  • VIATRIS PHARMACEUTICALS, SL

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    29 August 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 2ª PRORROGA ACUERDO MARCO PROCEDIMIENTO ABIERTO SUMINISTRO DE EVEROLIMUS 5 Y 10 MG ORAL (ANTINEOPLÁSICO) CON DESTINO AL SERVICIO DE FARMACIA DEL HCSC — won by ACCORD HEALTHCARE,S.L +4 — Skim